AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Healing

    GHK-Cu (50mg)

    Subcutaneous5 days/week50mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    Research-only — Cosmetic (topical) use unrestricted

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Research-only — no FDA/EMA approval
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Available sizes:
    50mg
    100mg
    200mg

    Research monograph

    See the full GHK-Cu encyclopedia page with mechanism, evidence tier, related variants and research context.

    Open monograph
    Free Access

    How It Works

    GHK-Cu is a naturally occurring tripeptide that complexes with copper ions to regulate multiple biological processes. Research has demonstrated its involvement in healing via enhanced gene expression of collagen and decorin, activation of tissue remodeling pathways, and regulation of genes related to antioxidant defense and anti-inflammatory responses. The peptide exhibits multifunctional activity in skin, nervous system, and vascular tissue, with documented gene-regulatory effects that extend beyond simple wound healing.

    Quick Start

    • Reconstitution: Add 3.0 mL sterile water → 16.67 mg/mL concentration.
    • Typical Range: 1.0–2.0 mg per injection (5 days/wk or 3×/wk).
    • Storage: Lyophilized: −20 °C; reconstituted: refrigerate 2–8 °C; use within 30 days.
    Detailed Protocol Data

    Conservative Approach (3 mL = 16.67 mg/mL · 5 days/wk)

    Educational only
    Vial Size— affects syringe units
    BAC Water3 mL
    Concentration16.67 mg/mL

    Route: Subcutaneous | Frequency: 5 days/week

    WeekDoseUnits (per injection)
    Weeks 1–4
    1.0 mg (1000 mcg)
    6 Units (0.06 mL)
    Weeks 5–8
    1.5 mg (1500 mcg)
    9 Units (0.09 mL)
    Weeks 9–12+
    2.0 mg (2000 mcg)
    12 Units (0.12 mL)

    Studies report administration once daily, 5 days/week subcutaneously. This gradual titration allows for assessment of individual tolerance. Alternative protocol: 2.0 mg 3×/week (e.g., Mon/Wed/Fri) — ~6 mg/wk.

    Related compounds

    Reconstitution Steps

    Bacteriostatic Water (BAC Water): GHK-Cu is hydrophilic and dissolves easily in BAC water (sterile water with 0.9% benzyl alcohol). Benzyl alcohol prevents bacterial growth, allowing multiple draws from the same vial.
    1. Withdraw 3.0 mL of bacteriostatic water (BAC water). Alternatively: 0.6% acetic acid may improve copper complex stability for long-term storage.
    2. Slowly inject down the side of the vial to minimize foaming.
    3. Gently swirl or rotate until fully dissolved (do not shake vigorously). The solution will have a slight blue tint (normal, due to the copper).
    4. Note the date of reconstitution and refrigerate at 2–8 °C, protecting from light.

    Protocol Overview

    • Objective: Support tissue remodeling, wound healing, and skin regeneration via documented biological pathways.
    • Schedule: Subcutaneous injections for 8–12 weeks (extendable to 16 if needed).
    • Storage: Lyophilized frozen; reconstituted refrigerated and used within 30 days.

    Dosing Protocol

    • Conservative (5 days/wk): Start at 1.0 mg daily; titrate to 1.5–2.0 mg over 4–8 weeks.
    • Alternative (3×/wk): Fixed 2.0 mg per injection for a simplified schedule.
    • Cycle Duration: 8–12 weeks typically; extendable to 16 weeks as needed.
    • Break between cycles: After the cycle (8–12 weeks), a washout period of 2–4 weeks is recommended. GHK-Cu supports tissue regeneration — the pause allows for evaluation of results.

    Washout & Cycle Restart

    When can I restart?

    After the cycle (8–12 weeks), a washout period of 2–4 weeks is recommended. GHK-Cu supports tissue regeneration — the pause allows for evaluation of results.

    Minimum wait period: 4 weeks

    Storage Instructions

    • Lyophilized (dry powder): Store at −20 °C or below in dry, dark conditions.
    • Reconstituted: Refrigerate at 2–8 °C; use within 30 days. Bacteriostatic water inhibits bacterial growth.
    • Aliquoting: For longer-term storage, aliquot into sterile vials and freeze at −20 °C. Avoid repeated freeze-thaw cycles.
    • Allow vials to reach room temperature before opening.

    Important Notes

    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Supports wound healing and tissue repair through collagen synthesis and remodeling pathways.
    • Positive regulatory effects on genes for antioxidant enzymes, growth factors, and anti-inflammatory signaling.
    • Activity in nervous system function and cognitive pathways in preclinical models.
    • Generally well-tolerated; most common side effects are mild injection site reactions (transient redness, itching).

    Potential Side Effects:

    • Injection site reactions (redness, itching — transient).
    • Local erythema or skin dryness (topical use).
    • Rare allergic reaction to the copper complex.

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    🎗️ Cancer Markers
    🟡 Moderate / Theoretical

    Angiogenesis & tissue remodeling

    GHK-Cu promotes angiogenesis, tissue regeneration, and increases collagen/elastin. Theoretical concern for enhancing existing tumors, though no clinical signal exists.

    📄 Life Sci 2012

    References

    1. J. Dermatological Science — GHK-Cu stimulates collagen synthesis and wound healing
      View Source
    2. Wound Repair and Regeneration (Wiley) — Copper peptides in healing: tissue remodeling and collagen
      View Source
    3. Int. J. Molecular Sciences (PMC) — Regenerative and protective actions of GHK-Cu: a gene regulation analysis
      View Source
    4. Biomaterials (Elsevier) — GHK regulation of metalloproteinases and tissue inhibitors
      View Source
    5. Brain Sciences (MDPI) — Effect of GHK on nervous system gene expression
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    0
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    Research peptide — No regulatory approval from any agency

    Research-only — Cosmetic (topical) use unrestricted

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu